Najeeb Al-Hallak相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease

利用PET检测IL12/23p40可可视化炎症性肠病

期刊:Journal of Nuclear Medicine

影响因子:9.1

doi:10.2967/jnumed.123.265649.

Farzaneh Rezazadeh ,Nicholas Ramos ,Allen-Dexter Saliganan ,Najeeb Al-Hallak ,Kang Chen ,Bashar Mohamad ,Wendy N Wiesend ,Nerissa T Viola

免疫/内分泌

发表日期：2023

文献求助收藏

Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model

XPO1 抑制剂与吉西他滨-白蛋白结合型紫杉醇联合治疗 KPC 胰腺癌小鼠模型的分子分析

期刊:Clinical and Translational Medicine

影响因子:7.9

doi:10.1002/ctm2.1513

Md Hafiz Uddin, Mohammad Najeeb Al-Hallak, Husain Yar Khan, Amro Aboukameel, Yiwei Li, Sahar F Bannoura, Gregory Dyson, Seongho Kim, Yosef Mzannar, Ibrahim Azar, Tanya Odisho, Amr Mohamed, Yosef Landesman, Steve Kim, Rafic Beydoun, Ramzi M Mohammad, Philip A Philip, Anthony F Shields, Asfar S Azmi

发表日期：2023

文献求助收藏

Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy

利用 CPI-613 靶向细胞代谢可增强胰腺癌细胞对放射疗法的敏感性

期刊:Advances in Radiation Oncology

影响因子:2.2

doi:10.1016/j.adro.2022.101122

Husain Yar Khan, Mandana Kamgar, Amro Aboukameel, Sahar Bannoura, Brian Y Chung, Yiwei Li, Mohammed Najeeb Al Hallak, Philip A Philip, Susan Tsai, Sanjeev Luther, William A Hall, Asfar S Azmi

发表日期：2022

文献求助收藏

Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers

核转运蛋白 XPO1 抑制剂可增强 KRAS G12C 抑制剂在 KRAS G12C 突变癌症临床前模型中的抗癌功效

期刊:Cancer Research Communications

doi:10.1158/2767-9764.crc-21-0176

Husain Yar Khan, Misako Nagasaka, Yiwei Li, Amro Aboukameel, Md Hafiz Uddin, Rachel Sexton, Sahar Bannoura, Yousef Mzannar, Mohammed Najeeb Al-Hallak, Steve Kim, Rafic Beydoun, Yosef Landesman, Hirva Mamdani, Dipesh Uprety, Philip A Philip, Ramzi M Mohammad, Anthony F Shields, Asfar S Azmi

发表日期：2022

文献求助收藏